Real-World Experience with Bigfoot Unity-A Twelve-Month Retrospective Analysis

被引：0
|
作者：
Tillman, John
Olson, Byron P.
Malone, James K.
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-1008-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1008-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The First Real-World Experience with Bigfoot Unity-A Three-Month Retrospective Analysis
    Baliga, Bantwal
    Tillman, John
    Olson, Byron P.
    Vaughan, Sarah
    Sheikh, F. Naureen
    Malone, James K.
    DIABETES, 2022, 71
  • [2] Golimumab in real-world practice in patients with ulcerative colitis: Twelve-month results
    Teich, Niels
    Gruemmer, Harald
    Joergensen, Eric
    Liceni, Thomas
    Holtkamp-Endemann, Frank
    Fischer, Tim
    Hohenberger, Susanne
    WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (21) : 2852 - 2863
  • [3] Golimumab in real-world practice in patients with ulcerative colitis:Twelve-month results
    Niels Teich
    Harald Grümmer
    Eric J?rgensen
    Thomas Liceni
    Frank Holtkamp-Endemann
    Tim Fischer
    Susanne Hohenberger
    World Journal of Gastroenterology, 2020, (21) : 2852 - 2863
  • [4] Nusinersen in type 1 spinal muscular atrophy: Twelve-month real-world data
    Pane, Marika
    Coratti, Giorgia
    Sansone, Valeria A.
    Messina, Sonia
    Bruno, Claudio
    Catteruccia, Michela
    Sframeli, Maria
    Albamonte, Emilio
    Pedemonte, Marina
    D'Amico, Adele
    Bravetti, Chiara
    Berti, Beatrice
    Brigati, Giorgia
    Tacchetti, Paola
    Salmin, Francesca
    de Sanctis, Roberto
    Lucibello, Simona
    Piastra, Marco
    Genovese, Orazio
    Bertini, Enrico
    Vita, Giuseppe
    Tiziano, Francesco Danilo
    Mercuri, Eugenio
    ANNALS OF NEUROLOGY, 2019, 86 (03) : 443 - 451
  • [5] Twelve-month safety, tolerability and susceptibility to adverse events of prophylactic migraine therapy with erenumab: a retrospective real-world study
    Hannah Schenk
    Dagny Holle
    Michael Nsaka
    Christoph Kleinschnitz
    Martin Glas
    Armin Scheffler
    The Journal of Headache and Pain, 2022, 23
  • [6] Twelve-month safety, tolerability and susceptibility to adverse events of prophylactic migraine therapy with erenumab: a retrospective real-world study
    Schenk, Hannah
    Holle, Dagny
    Nsaka, Michael
    Kleinschnitz, Christoph
    Glas, Martin
    Scheffler, Armin
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01):
  • [7] Twelve-month clinical outcomes of sirolimus-eluting stent in coronary artery disease: An experience in real-world Indian patients
    Nathani, Srikanth
    Raheem, Asif
    Sanadhya, Harish
    Purohit, Prakash Chandra
    Patel, Ramesh
    Alane, Praveen K.
    Agarwal, Deepeshkumar
    Sinha, Ramanand
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2020, 24 (06): : 364 - 369
  • [8] Twelve-Month Efficacy of Lacosamide Monotherapy at Maximal Dose and Tolerability for Epilepsy Treatment in Pediatric Patients: Real-World Clinical Experience
    Zhao, Ting
    Li, Hong-jian
    Zhang, Hui-lan
    Yu, Jing
    Feng, Jie
    Wang, Ting-ting
    Sun, Yan
    Yu, Lu-hai
    PEDIATRIC NEUROLOGY, 2023, 142 : 23 - 30
  • [9] Twelve-month analysis of real-world evidence from a telehealth obesity-treatment provider using antiobesity medications
    Ard, Jamy D.
    Hong, Young-Rock
    Foster, Gary D.
    Medcalf, Adam
    Nadolsky, Spencer
    Cardel, Michelle I.
    OBESITY, 2024, 32 (12) : 2246 - 2254
  • [10] Three-Month Interim Analysis from the Prospective Bigfoot Unity Real World Study (BURST)
    Malone, James K.
    Beck, Roy
    Tillman, John
    Calhoun, Peter
    Mouse, Thomas J.
    Bailey, Ryan
    Olson, Byron P.
    Vaughan, Sarah
    Sheikh, F. Naureen
    DIABETES, 2023, 72
12345